PL3719021T3 - Inhibitory kinazy 1 związanej z adapterem, kompozycje je zawierające, oraz sposoby ich zastosowania - Google Patents
Inhibitory kinazy 1 związanej z adapterem, kompozycje je zawierające, oraz sposoby ich zastosowaniaInfo
- Publication number
- PL3719021T3 PL3719021T3 PL20177604T PL20177604T PL3719021T3 PL 3719021 T3 PL3719021 T3 PL 3719021T3 PL 20177604 T PL20177604 T PL 20177604T PL 20177604 T PL20177604 T PL 20177604T PL 3719021 T3 PL3719021 T3 PL 3719021T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- compositions
- methods
- associated kinase
- adapter associated
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953976P | 2014-03-17 | 2014-03-17 | |
| PCT/US2015/020696 WO2015142714A1 (en) | 2014-03-17 | 2015-03-16 | Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use |
| EP15712026.2A EP3119783B1 (en) | 2014-03-17 | 2015-03-16 | Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use |
| EP20177604.4A EP3719021B1 (en) | 2014-03-17 | 2015-03-16 | Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3719021T3 true PL3719021T3 (pl) | 2022-06-20 |
Family
ID=52727478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20177604T PL3719021T3 (pl) | 2014-03-17 | 2015-03-16 | Inhibitory kinazy 1 związanej z adapterem, kompozycje je zawierające, oraz sposoby ich zastosowania |
| PL15712026T PL3119783T3 (pl) | 2014-03-17 | 2015-03-16 | Inhibitory kinazy 1 oddziałującej z adaptorem, kompozycje je zawierające i sposoby ich zastosowania |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15712026T PL3119783T3 (pl) | 2014-03-17 | 2015-03-16 | Inhibitory kinazy 1 oddziałującej z adaptorem, kompozycje je zawierające i sposoby ich zastosowania |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9682982B2 (enExample) |
| EP (2) | EP3119783B1 (enExample) |
| JP (1) | JP6553081B2 (enExample) |
| CN (1) | CN106103447B (enExample) |
| AR (1) | AR099766A1 (enExample) |
| AU (1) | AU2015231672B2 (enExample) |
| CA (1) | CA2941870C (enExample) |
| DK (2) | DK3719021T3 (enExample) |
| ES (2) | ES2821441T3 (enExample) |
| HU (1) | HUE050975T2 (enExample) |
| PL (2) | PL3719021T3 (enExample) |
| PT (2) | PT3119783T (enExample) |
| TW (1) | TW201620911A (enExample) |
| WO (1) | WO2015142714A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014022000A8 (pt) * | 2012-03-09 | 2021-06-15 | Lexicon Pharmaceuticals Inc | compostos à base de pirazol[1,5-a]pirimidina, seu uso e composições que os compreende |
| ES2678877T3 (es) | 2013-10-11 | 2018-08-20 | Bristol-Myers Squibb Company | Inhibidores de pirrolotriazina quinasa |
| CN109369576B (zh) * | 2018-09-19 | 2020-11-27 | 上海凌凯医药科技有限公司 | 一种合成3-甲基氧杂环丁烷-3-(4-硝基苯基)碳酸酯的方法 |
| CA3175973A1 (en) * | 2020-04-21 | 2021-10-28 | Lexicon Pharmaceuticals, Inc. | 4-(3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)piperazine for use in the the treatment of cov-229e or cov-oc43 coronaviruses infections |
| CA3175970A1 (en) | 2020-04-21 | 2021-10-28 | Suma GOPINATHAN | Aak1 inhibitors for use in treating viral infections |
| WO2023196584A2 (en) * | 2022-04-08 | 2023-10-12 | New York University | Endocytosis inhibitors and their use for pain treatment |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| US6194410B1 (en) * | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
| EP1873157A1 (en) * | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| US8591943B2 (en) * | 2009-04-09 | 2013-11-26 | Merck Sharp & Dohme Corp. | Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors |
| UA110324C2 (en) * | 2009-07-02 | 2015-12-25 | Genentech Inc | Jak inhibitory compounds based on pyrazolo pyrimidine |
| WO2011030139A1 (en) * | 2009-09-11 | 2011-03-17 | Astrazeneca Ab | 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
| EP2523552B1 (en) * | 2010-01-14 | 2015-05-13 | Merck Sharp & Dohme Corp. | Pyrazolo[1,5-a]pyrimidines as mark inhibitors |
| WO2012034095A1 (en) * | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| EP2822559B1 (en) * | 2012-03-09 | 2018-05-02 | Lexicon Pharmaceuticals, Inc. | Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and uses thereof |
| AU2013230066A1 (en) * | 2012-03-09 | 2014-09-25 | Lexicon Pharmaceuticals, Inc. | Inhibition of adaptor associated kinase 1 for the treatment of pain |
| BR112014022000A8 (pt) * | 2012-03-09 | 2021-06-15 | Lexicon Pharmaceuticals Inc | compostos à base de pirazol[1,5-a]pirimidina, seu uso e composições que os compreende |
-
2015
- 2015-03-04 TW TW104106872A patent/TW201620911A/zh unknown
- 2015-03-16 PL PL20177604T patent/PL3719021T3/pl unknown
- 2015-03-16 CA CA2941870A patent/CA2941870C/en active Active
- 2015-03-16 DK DK20177604.4T patent/DK3719021T3/da active
- 2015-03-16 EP EP15712026.2A patent/EP3119783B1/en active Active
- 2015-03-16 CN CN201580014255.6A patent/CN106103447B/zh active Active
- 2015-03-16 DK DK15712026.2T patent/DK3119783T3/da active
- 2015-03-16 HU HUE15712026A patent/HUE050975T2/hu unknown
- 2015-03-16 WO PCT/US2015/020696 patent/WO2015142714A1/en not_active Ceased
- 2015-03-16 EP EP20177604.4A patent/EP3719021B1/en active Active
- 2015-03-16 PT PT157120262T patent/PT3119783T/pt unknown
- 2015-03-16 AU AU2015231672A patent/AU2015231672B2/en active Active
- 2015-03-16 AR ARP150100787A patent/AR099766A1/es unknown
- 2015-03-16 PT PT201776044T patent/PT3719021T/pt unknown
- 2015-03-16 US US14/658,653 patent/US9682982B2/en active Active
- 2015-03-16 PL PL15712026T patent/PL3119783T3/pl unknown
- 2015-03-16 ES ES15712026T patent/ES2821441T3/es active Active
- 2015-03-16 ES ES20177604T patent/ES2911388T3/es active Active
- 2015-03-16 JP JP2016557251A patent/JP6553081B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2911388T3 (es) | 2022-05-19 |
| PT3719021T (pt) | 2022-04-08 |
| US9682982B2 (en) | 2017-06-20 |
| CA2941870C (en) | 2022-07-19 |
| US20160039824A1 (en) | 2016-02-11 |
| EP3719021A1 (en) | 2020-10-07 |
| EP3119783A1 (en) | 2017-01-25 |
| ES2821441T3 (es) | 2021-04-26 |
| DK3719021T3 (da) | 2022-06-13 |
| AR099766A1 (es) | 2016-08-17 |
| EP3719021B1 (en) | 2022-03-09 |
| WO2015142714A1 (en) | 2015-09-24 |
| HUE050975T2 (hu) | 2021-01-28 |
| HK1226065A1 (zh) | 2017-09-22 |
| CA2941870A1 (en) | 2015-09-24 |
| EP3119783B1 (en) | 2020-06-24 |
| TW201620911A (zh) | 2016-06-16 |
| PT3119783T (pt) | 2020-09-24 |
| PL3119783T3 (pl) | 2021-01-11 |
| AU2015231672A1 (en) | 2016-09-15 |
| CN106103447A (zh) | 2016-11-09 |
| JP2017507980A (ja) | 2017-03-23 |
| CN106103447B (zh) | 2019-07-16 |
| DK3119783T3 (da) | 2020-09-28 |
| JP6553081B2 (ja) | 2019-07-31 |
| AU2015231672B2 (en) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3277681T3 (pl) | Imidazolonylochinoliny i ich zastosowanie jako inhibitorów kinazy atm | |
| ZA201700786B (en) | Protein kinase c inhibitors and methods of their use | |
| HUE056172T2 (hu) | Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra | |
| GB201611188D0 (en) | Cementing compositions and methods | |
| ZA201700021B (en) | Alk kinase inhibitor, and preparation method and use thereof | |
| ZA202005857B (en) | Oligonucleotide compositions and methods of making the same | |
| EP3190886A4 (en) | Compositions and methods of use thereof | |
| HUE050975T2 (hu) | Adapter-asszociált kináz 1 inhibitorai, azokat tartalmazó kompozíciók és eljárások alkalmazásukra | |
| PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
| IL258690A (en) | Pyridone derivatives and their use as kinase inhibitors | |
| EP3207029A4 (en) | Tryptamide compositions and methods of use | |
| IL261794A (en) | Preparations and methods for using them | |
| GB201609580D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201705201D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201509381D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201409661D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201405532D0 (en) | Novel compounds and their use as Kinase inhibitors | |
| GB201505460D0 (en) | Novel compounds and their use as kinase inhibitors | |
| AU2014905067A0 (en) | Compositions and methods of use | |
| AU2014902829A0 (en) | Compositions and Methods of Use |